Cargando…

Clinical and Magnetic Resonance Imaging Predictors of Very Early Neurological Response to Intravenous Thrombolysis in Patients With Middle Cerebral Artery Occlusion

BACKGROUND: The early identification of patients who are unlikely to respond to intravenous recombinant tissue plasminogen activator (IV‐tPA) could help select candidates for additional intra‐arterial therapy or add‐on antithrombotic drugs during the acute stage of stroke. Given that very early neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Apoil, Marion, Turc, Guillaume, Tisserand, Marie, Calvet, David, Naggara, Olivier, Domigo, Valérie, Baron, Jean‐Claude, Oppenheim, Catherine, Touzé, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886747/
https://www.ncbi.nlm.nih.gov/pubmed/24308937
http://dx.doi.org/10.1161/JAHA.113.000511
_version_ 1782478915518857216
author Apoil, Marion
Turc, Guillaume
Tisserand, Marie
Calvet, David
Naggara, Olivier
Domigo, Valérie
Baron, Jean‐Claude
Oppenheim, Catherine
Touzé, Emmanuel
author_facet Apoil, Marion
Turc, Guillaume
Tisserand, Marie
Calvet, David
Naggara, Olivier
Domigo, Valérie
Baron, Jean‐Claude
Oppenheim, Catherine
Touzé, Emmanuel
author_sort Apoil, Marion
collection PubMed
description BACKGROUND: The early identification of patients who are unlikely to respond to intravenous recombinant tissue plasminogen activator (IV‐tPA) could help select candidates for additional intra‐arterial therapy or add‐on antithrombotic drugs during the acute stage of stroke. Given that very early neurological improvement (VENI) is a reliable surrogate of early recanalization, we assessed the clinical and magnetic resonance imaging predictors of lack of VENI. METHODS AND RESULTS: We reviewed consecutive ischemic stroke patients with middle cerebral artery occlusion and treated within 4.5 hours by IV‐tPA between 2003 and 2012 in our center, where magnetic resonance imaging is systematically implemented as first‐line diagnostic workup. Lack of VENI was defined as a <40% decrease in baseline National Institutes of Health Stroke Scale (NIHSS) score 1 hour after start of IV‐tPA. Poor outcome was defined as a 3‐month modified Rankin scale ≥2. Associations between lack of VENI and potential determinants were assessed in logistic regression models. In all, 186 patients were included (median baseline NIHSS score, 16; median onset to treatment time, 155 minutes). One hundred forty‐three patients (77%) had no VENI. The variables significantly associated with lack of VENI in multivariable analysis were baseline NIHSS (OR, 1.08; 95% CI, 1.01 to 1.16 per 1‐point increase; P=0.03), onset to treatment time >120 minutes (OR, 2.94; 95% CI, 1.31 to 6.63; P=0.009) and diffusion weighted imaging—Alberta Stroke Programme Early CT Score ≤5 (OR, 3.60; 95% CI, 1.14 to 11.35; P=0.03). Patients without VENI were more likely to have a modified Rankin Scale ≥2 than those without VENI (68% versus 24%; OR, 5.01; 95% CI, 2.12 to 11.82) and less likely to have recanalization after 24 hours (OR, 0.41; 95% CI, 0.19 to 0.88). CONCLUSIONS: Lack of VENI provides an early estimate of 3‐month outcome and recanalization after IV‐tPA. Baseline NIHSS, onset to treatment time, and diffusion weighted imaging—Alberta Stroke Programme Early CT Score could help to predict lack of VENI and, in turn, might help early selection of candidates for complementary reperfusion strategies.
format Online
Article
Text
id pubmed-3886747
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-38867472014-01-10 Clinical and Magnetic Resonance Imaging Predictors of Very Early Neurological Response to Intravenous Thrombolysis in Patients With Middle Cerebral Artery Occlusion Apoil, Marion Turc, Guillaume Tisserand, Marie Calvet, David Naggara, Olivier Domigo, Valérie Baron, Jean‐Claude Oppenheim, Catherine Touzé, Emmanuel J Am Heart Assoc Original Research BACKGROUND: The early identification of patients who are unlikely to respond to intravenous recombinant tissue plasminogen activator (IV‐tPA) could help select candidates for additional intra‐arterial therapy or add‐on antithrombotic drugs during the acute stage of stroke. Given that very early neurological improvement (VENI) is a reliable surrogate of early recanalization, we assessed the clinical and magnetic resonance imaging predictors of lack of VENI. METHODS AND RESULTS: We reviewed consecutive ischemic stroke patients with middle cerebral artery occlusion and treated within 4.5 hours by IV‐tPA between 2003 and 2012 in our center, where magnetic resonance imaging is systematically implemented as first‐line diagnostic workup. Lack of VENI was defined as a <40% decrease in baseline National Institutes of Health Stroke Scale (NIHSS) score 1 hour after start of IV‐tPA. Poor outcome was defined as a 3‐month modified Rankin scale ≥2. Associations between lack of VENI and potential determinants were assessed in logistic regression models. In all, 186 patients were included (median baseline NIHSS score, 16; median onset to treatment time, 155 minutes). One hundred forty‐three patients (77%) had no VENI. The variables significantly associated with lack of VENI in multivariable analysis were baseline NIHSS (OR, 1.08; 95% CI, 1.01 to 1.16 per 1‐point increase; P=0.03), onset to treatment time >120 minutes (OR, 2.94; 95% CI, 1.31 to 6.63; P=0.009) and diffusion weighted imaging—Alberta Stroke Programme Early CT Score ≤5 (OR, 3.60; 95% CI, 1.14 to 11.35; P=0.03). Patients without VENI were more likely to have a modified Rankin Scale ≥2 than those without VENI (68% versus 24%; OR, 5.01; 95% CI, 2.12 to 11.82) and less likely to have recanalization after 24 hours (OR, 0.41; 95% CI, 0.19 to 0.88). CONCLUSIONS: Lack of VENI provides an early estimate of 3‐month outcome and recanalization after IV‐tPA. Baseline NIHSS, onset to treatment time, and diffusion weighted imaging—Alberta Stroke Programme Early CT Score could help to predict lack of VENI and, in turn, might help early selection of candidates for complementary reperfusion strategies. Blackwell Publishing Ltd 2013-12-19 /pmc/articles/PMC3886747/ /pubmed/24308937 http://dx.doi.org/10.1161/JAHA.113.000511 Text en © 2013 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Apoil, Marion
Turc, Guillaume
Tisserand, Marie
Calvet, David
Naggara, Olivier
Domigo, Valérie
Baron, Jean‐Claude
Oppenheim, Catherine
Touzé, Emmanuel
Clinical and Magnetic Resonance Imaging Predictors of Very Early Neurological Response to Intravenous Thrombolysis in Patients With Middle Cerebral Artery Occlusion
title Clinical and Magnetic Resonance Imaging Predictors of Very Early Neurological Response to Intravenous Thrombolysis in Patients With Middle Cerebral Artery Occlusion
title_full Clinical and Magnetic Resonance Imaging Predictors of Very Early Neurological Response to Intravenous Thrombolysis in Patients With Middle Cerebral Artery Occlusion
title_fullStr Clinical and Magnetic Resonance Imaging Predictors of Very Early Neurological Response to Intravenous Thrombolysis in Patients With Middle Cerebral Artery Occlusion
title_full_unstemmed Clinical and Magnetic Resonance Imaging Predictors of Very Early Neurological Response to Intravenous Thrombolysis in Patients With Middle Cerebral Artery Occlusion
title_short Clinical and Magnetic Resonance Imaging Predictors of Very Early Neurological Response to Intravenous Thrombolysis in Patients With Middle Cerebral Artery Occlusion
title_sort clinical and magnetic resonance imaging predictors of very early neurological response to intravenous thrombolysis in patients with middle cerebral artery occlusion
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886747/
https://www.ncbi.nlm.nih.gov/pubmed/24308937
http://dx.doi.org/10.1161/JAHA.113.000511
work_keys_str_mv AT apoilmarion clinicalandmagneticresonanceimagingpredictorsofveryearlyneurologicalresponsetointravenousthrombolysisinpatientswithmiddlecerebralarteryocclusion
AT turcguillaume clinicalandmagneticresonanceimagingpredictorsofveryearlyneurologicalresponsetointravenousthrombolysisinpatientswithmiddlecerebralarteryocclusion
AT tisserandmarie clinicalandmagneticresonanceimagingpredictorsofveryearlyneurologicalresponsetointravenousthrombolysisinpatientswithmiddlecerebralarteryocclusion
AT calvetdavid clinicalandmagneticresonanceimagingpredictorsofveryearlyneurologicalresponsetointravenousthrombolysisinpatientswithmiddlecerebralarteryocclusion
AT naggaraolivier clinicalandmagneticresonanceimagingpredictorsofveryearlyneurologicalresponsetointravenousthrombolysisinpatientswithmiddlecerebralarteryocclusion
AT domigovalerie clinicalandmagneticresonanceimagingpredictorsofveryearlyneurologicalresponsetointravenousthrombolysisinpatientswithmiddlecerebralarteryocclusion
AT baronjeanclaude clinicalandmagneticresonanceimagingpredictorsofveryearlyneurologicalresponsetointravenousthrombolysisinpatientswithmiddlecerebralarteryocclusion
AT oppenheimcatherine clinicalandmagneticresonanceimagingpredictorsofveryearlyneurologicalresponsetointravenousthrombolysisinpatientswithmiddlecerebralarteryocclusion
AT touzeemmanuel clinicalandmagneticresonanceimagingpredictorsofveryearlyneurologicalresponsetointravenousthrombolysisinpatientswithmiddlecerebralarteryocclusion